Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is the most common benign, often multifocal neoplasm of the larynx and trachea. Despite its benign histology, RRP is a potentially fatal manifestation of human papillomavirus infection. RRP is rare; the annual incidence rate is estimated at 0.35 per 100,000 persons with a prevalence of 4 in 100,000 children. RRP is characterized by the growth of wart-like lesions in the aerodigestive tract, often having a cauliflower-like appearance. They are either pedunculated or sessile and show a tremendous predilection for the larynx. Hoarseness is the leading symptom of RRP, although some children do not present until they develop life-threatening airway obstruction. Affected patients usually require multiple interventions and in severe cases even tracheotomy is needed. Surgical excision is the mainstay of therapy, but it often only alleviates symptoms of the disease. The clinical course of RRP is characterized by adamant recurrences even after seemingly complete surgical excision. The frequency of recurrence, the severity of disease and age of spontaneous remission are variable and unpredictable. To date, there is insufficient evidence to support effectiveness of adjuvant medical treatment in the management of RRP. The clinical course including patient’s history, physical examination, airway endoscopy, surgical and nonsurgical treatment modalities are discussed. Additionally, the cause of RRP, mode of transmission, pathogenesis, and the outcome are presented in this article.

[1]  D. Lindquist,et al.  Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort , 2014, Acta oto-laryngologica.

[2]  H. Trottier,et al.  Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: a systematic review. , 2014, International journal of pediatric otorhinolaryngology.

[3]  J. Doorbar Latent papillomavirus infections and their regulation. , 2013, Current opinion in virology.

[4]  N. Muñoz,et al.  Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia , 2013, Head & neck.

[5]  Wim Quint,et al.  The biology and life-cycle of human papillomaviruses. , 2012, Vaccine.

[6]  E. R. van den Heuvel,et al.  Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis , 2012, The Laryngoscope.

[7]  H. Akre,et al.  Epidemiological aspects of recurrent respiratory papillomatosis: A population‐based study , 2012, The Laryngoscope.

[8]  M. Stanley Epithelial Cell Responses to Infection with Human Papillomavirus , 2012, Clinical Microbiology Reviews.

[9]  H. Sings,et al.  The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[10]  J. Hocking,et al.  The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme , 2011, Sexually Transmitted Infections.

[11]  R. Roine,et al.  Clinical features, health‐related quality of life, and adult voice in juvenile‐onset recurrent respiratory papillomatosis , 2011, The Laryngoscope.

[12]  M. Hawkes,et al.  The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database , 2010, The Laryngoscope.

[13]  A. Donne,et al.  Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children , 2010, International journal of STD & AIDS.

[14]  B. Steinberg,et al.  Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus‐6 and ‐11 , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  Daniel A. Larson,et al.  Epidemiology of recurrent respiratory papillomatosis , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[16]  E. de Villiers,et al.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. , 2010, Virology.

[17]  S. Preuss,et al.  In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis , 2010, The Laryngoscope.

[18]  N. Chadha,et al.  Adjuvant antiviral therapy for recurrent respiratory papillomatosis. , 2010, The Cochrane database of systematic reviews.

[19]  M. Pawlita,et al.  [Recurrent respiratory papillomatosis: indication for HPV vaccination?]. , 2009, Deutsche medizinische Wochenschrift.

[20]  D. Lott,et al.  Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis , 2009, The Laryngoscope.

[21]  M. Evander,et al.  Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism , 2008, Virology Journal.

[22]  B. Wiatrak,et al.  Recurrent Respiratory Papillomatosis: A Review , 2008, The Laryngoscope.

[23]  J. Donfack,et al.  Age of Child, More than HPV Type, Is Associated with Clinical Course in Recurrent Respiratory Papillomatosis , 2008, PloS one.

[24]  J. Manoukian,et al.  Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature. , 2008, International journal of pediatric otorhinolaryngology.

[25]  M. Hawkes,et al.  Time Course of Juvenile Onset Recurrent Respiratory Papillomatosis Caused by Human Papillomavirus , 2008, The Pediatric infectious disease journal.

[26]  C. Liao,et al.  High Incidence of Malignant Transformation of Laryngeal Papilloma in Taiwan , 2008, The Laryngoscope.

[27]  M. Stanley,et al.  Recurrent respiratory papillomatosis: an overview of current thinking and treatment , 2007, European Archives of Oto-Rhino-Laryngology.

[28]  O. Guntinas-Lichius,et al.  Long-term results of surgical treatment for recurrent respiratory papillomatosis , 2007, Acta oto-laryngologica.

[29]  Edson Duarte Moreira Júnior,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. , 2007, The New England journal of medicine.

[30]  M. Mccormick,et al.  British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis. , 2006, International journal of pediatric otorhinolaryngology.

[31]  L. Laimins,et al.  Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity , 2006, Reviews in medical virology.

[32]  M. Wieringa,et al.  Reproducibility of the Dutch Version of the Voice Handicap Index , 2006, Folia Phoniatrica et Logopaedica.

[33]  F. Dikkers Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir—a prospective study , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[34]  B. Wiatrak,et al.  HspE7 Treatment of Pediatric Recurrent Respiratory Papillomatosis: Final Results of an Open-Label Trial , 2005, The Annals of otology, rhinology, and laryngology.

[35]  Jonathan P Lindman,et al.  Use of the Pediatric Quality of Life Inventory to Assess the Health-Related Quality of Life in Children with Recurrent Respiratory Papillomatosis , 2005, The Annals of otology, rhinology, and laryngology.

[36]  T. R. Broker,et al.  Recurrent Respiratory Papillomatosis: A Longitudinal Study Comparing Severity Associated With Human Papilloma Viral Types 6 and 11 and Other Risk Factors in a Large Pediatric Population , 2004, The Laryngoscope.

[37]  J. Field,et al.  Integration of Human Papillomavirus Type 11 in Recurrent Respiratory Papilloma‐Associated Cancer , 2004, The Laryngoscope.

[38]  K. Shah,et al.  Clinical course of recurrent respiratory papillomatosis in Danish children. , 2004, Archives of otolaryngology--head & neck surgery.

[39]  P. Froehlich,et al.  Intralesional Cidofovir and Surgical Excision for Laryngeal Papillomatosis , 2003, The Laryngoscope.

[40]  K. Shah,et al.  Condyloma in Pregnancy Is Strongly Predictive of Juvenile‐Onset Recurrent Respiratory Papillomatosis , 2003, Obstetrics and gynecology.

[41]  W. Lancaster,et al.  Human Papillomavirus-11-associated Recurrent Respiratory Papillomatosis Is More Aggressive Than Human Papillomavirus-6-associated Disease , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[42]  W. Reeves,et al.  Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. , 1999, Archives of otolaryngology--head & neck surgery.

[43]  R. Zappatore,et al.  Perinatal transmission of human papillomavirus from gravidas with latent infections. , 1999, Obstetrics and gynecology.

[44]  H. Kashima,et al.  A Staging System for Assessing Severity of Disease and Response to Therapy in Recurrent Respiratory Papillomatosis , 1998, The Laryngoscope.

[45]  K. Shah,et al.  Risk factors for juvenile onset recurrent respiratory papillomatosis , 1998 .

[46]  B. Rose,et al.  Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis , 1997, Journal of clinical microbiology.

[47]  G. Ehrlich,et al.  Pediatric Respiratory Papillomatosis: Prognostic Role of Viral Typing and Cofactors , 1997, The Laryngoscope.

[48]  C. Derkay,et al.  Role of cesarean section in prevention of recurrent respiratory papillomatosis--is there one? , 1996, International journal of pediatric otorhinolaryngology.

[49]  S. Syrjänen,et al.  Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. , 1996, American journal of obstetrics and gynecology.

[50]  C. Derkay Task force on recurrent respiratory papillomas. A preliminary report. , 1995, Archives of otolaryngology--head & neck surgery.

[51]  R. Hruban,et al.  Sites of Predilection in Recurrent Respiratory Papillomatosis , 1993, The Annals of otology, rhinology, and laryngology.

[52]  B. Kotecha,et al.  Ribavirin treatment for juvenile respiratory papillomatosis , 1993, The Journal of Laryngology & Otology.

[53]  C. Prescott,et al.  Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children's Hospital experience 1982-1988. , 1993, International journal of pediatric otorhinolaryngology.

[54]  H. Kashima,et al.  A comparison of risk factors in juvenile‐onset and adult‐onset recurrent respiratory papillomatosis , 1992, The Laryngoscope.

[55]  R. Cole,et al.  Tracheotomy in children with recurrent respiratory papillomatosis , 1989, Head & neck.

[56]  S. Syrjänen,et al.  Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. , 1989, Acta oto-laryngologica.

[57]  R. Gelber,et al.  Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. , 1988, The New England journal of medicine.

[58]  B. Leventhal,et al.  Recurrent respiratory papillomatosis. , 1985, Journal of biological response modifiers.